Clinical Trial Update: Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating a hyperproteic diet combined with Lactobacillus reuteri and nitazoxanide for minimal hepatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cirrhosis
• Minimal Hepatic Encephalopathy

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)
• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Hepatic Cirrhosis, Minimal Hepatic Encephalopathy | NA | Status: COMPLETED